Mission
The mission of this Office is to prevent, find and remediate problems in research compliance. In carrying out its mission the Office is guided by Seven Elements of an Effective Compliance Program developed by the federal government:
- Establish Policies, Procedures and Controls
- Exercise Effective Compliance and Ethics Oversight
- Exercise Due Diligence in Delegating Authority to Individuals
- Communicate and Educate Employees on the Compliance Programs
- Monitor and Audit Compliance Programs for Effectiveness
- Ensure Consistent Enforcement and Discipline of Violations
- Respond Appropriately to Incidents and Take Steps to Prevent Future Incidents
To ensure compliance with federal, state, and university requirements for conducting research, CMU has established several boards/committees that are charged with the oversight of research conducted in their respective areas.
|
CMU has policies and procedures that govern research involving the participation of humans as subjects. Research encompasses work that is conducted on or off campus and includes questionnaires, interviews, test, observations, surveys, and other experiments, regardless of the content or routine nature of the subject's involvement and even if this work is preliminary to a more extensive study. All research involving human subjects must be approved by the Institutional Review Board (IRB). The Vice President for Research is the Institutional Official (IO) for the Human Research Protection Program. The Director of the Office of Research Compliance is the Human Research Protection Administrator. |
|
CMU policy specifies that all vertebrate animals under university care will be treated humanely and that the university will comply with federal and state regulations regarding animal care and use. Responsibility for assuring institutional compliance with state and federal regulations has been delegated to the Vice President for Research, who is advised by the Institutional Animal Care and Use Committee. |
|
CMU and researchers must abide by the National Institutes of Health's
Guidelines for Research Involving Recombinant DNA Molecules. All recombinant DNA projects must also be approved by the CMU Institutional Biosafety Committee and have a completed and signed Recombinant DNA Agreement Statement on file before initiating the research. |
Other Offices with Compliance Responsibilities
|
Bloodborne Pathogens, HIV, HBV
Exposure Control Officer--Risk Management, Environmental Health and Safety
Smith Hall 103 989-774-3741
|
Biological, Chemical, or Radiation Hazards
Director--Office of Laboratory and Field Safety
Foust Hall 104 989-774-4189
|
Updated 7/13/2016
Report a Research Concern